Better Science, Better Health – IP: Barrier or Creator of Sustainable Healthcare?

4 October, 7.30-8.45 CET, Bad Hofgastein This breakfast session will offer an open debate on the role of IP in EU healthcare innovation, focused on the appropriate role and balance for both public funding and private investments, supported by new research on EU biotech success factors produced by Vital Transformation.

WEBINAR – IMI Get Real: Launch PragMagic – an innovative tool to assist pragmatic trial design


June 8th, 2017
In this webinar we introduced our view on pragmatic trials, discuss the forces at work that we captured in the tool and the game and usability of the design of the tool. We’ll finish with a demonstration of the tool.

WEBINAR: Can Europe bring the next generation of biotech therapies to market?


February 13th, 2017
This webinar will discuss the mounting challenges to Europe's ATMP sector, and offer tangible suggestions as to what needs to be done to ensure the EU maintains its ability to develop needed new therapies and bring them to patients

WEBINAR: “IMI GetReal’s RWE Navigator – Making Real World Evidence Real”


March 8th, 2017
This webinar will present an overview of the challenges to drug development from the standpoint of the need for new sources of evidence. It will also include a presentation on what the 'RWE Navigator' is, and what it does with a live demonstration of the web tool.

WEBINAR: GetReal – Identifying the Operational challenges of Performing RWE Research (WP3)


October 6, 2016
WP 3 has two main goals. Identify operational challenges when implementing RWE research to investigate the effectiveness of medicines, earlier in the medicine development process. Second, to estimate the impact of these challenges on the ability to generate the RWE originally aimed for and the feasibility of the research and provide practical solutions to help address them. This webinar will update you on these goals.

DIA 2016: #302 Europe and the US: Making Outcomes-Based Health Care Possible

June 29, 2016, Philadelphia Europe and the US are experimenting with ways to develop therapies based on their actual ‘real world’ performance. This session will discuss the benefits and challenges of outcomes-based health care, as well as the remaining barriers to implementation.

Go to Top